Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year.

Clin Pharmacol Ther · 2019 · PMC6590383 · PMID 30506669

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Interestingly, with migalastat therapy, we observed a trend in increasing vitamin D levels, but it did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

The 10 patients without vitamin D supplementation (in all four groups) showed a trend for increase in serum vitamin D ( Table 3 ), with variances of 5.5, 8.4, 0.6, and 9.9 μg/L.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.